flutamide has been researched along with Experimental Neoplasms in 2 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cancer of the prostate is the most frequent cancer and the second leading cause of cancer death in men in North America." | 1.29 | Large Shionogi tumors lose their responsiveness to flutamide treatment. ( Chen, C; Labrie, F; Poulin, R, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C | 1 |
| Poulin, R | 1 |
| Labrie, F | 1 |
| Sandberg, AA | 1 |
1 review available for flutamide and Experimental Neoplasms
| Article | Year |
|---|---|
Potential test systems for chemotherapeutic agents against prostatic cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Animals; Antineoplastic Agents; Arginase; Dihydrot | 1975 |
1 other study available for flutamide and Experimental Neoplasms
| Article | Year |
|---|---|
Large Shionogi tumors lose their responsiveness to flutamide treatment.
Topics: Animals; Antineoplastic Agents, Hormonal; Carcinoma; Cell Division; Flutamide; Humans; Male; Mice; N | 1996 |